A. Rich (Nottingham (Nottinghamshire), United Kingdom), D. Jovanovic (Beograd, Republic of Serbia), W. van Geffen (Leeuwarden, Netherlands), M. Tor (Istanbul, Turkey)
Residential radon and lung cancer risk in never smokers in a radon prone aerea in Spain.
M. Lorenzo Gonzalez (Santiago de Compostela, Spain), M. Torres Duran (Vigo, Spain), I. Parente Lamelas (Ourense, Spain), V. Leiro Fernandez (Vigo, Spain), J. Abal Arca (Ourense, Spain), C. Montero Martínez (A COruña, Spain), O. Castro Anon (Lugo, Spain), M. Provencio Pulla (Madrid, Spain), I. Vidal Garcia (A COruña, Spain), A. Golpe Gómez (Santiago de Compostela, Spain), C. Martinez (Oviedo, Spain), R. Guzman Taveras (Oviedo, Spain), M. Amenedo Gancedo (A Coruña, Spain), A. Fernandez Villar (Vigo, Spain), J. Barros Dios (Santiago de Compostela, Spain), A. Ruano Ravina (Santiago de Compostela, Spain)
|   |
Prospective association between sedentary lifestyle and incidence of lung cancer in Norwegian adults: the HUNT study
L. Jiang (Trondheim, Norway), Y. Sun (Trondheim, Norway), B. Brumpton (Trondheim, Norway), A. Langhammer (Trondheim, Norway), Y. Chen (Ottawa, Canada), T. Nilsen (Trondheim, Norway), X. Mai (Trondheim, Norway)
| |
Anemia during lung cancer
S. Souilah (Algiers, Algeria), N. Dermech (Algiers, Algeria), Y. Benbetka (Algiers, Algeria), N. Djami (Algiers, Algeria), K. Khennouf (Algiers, Algeria), R. Amrane (Algiers, Algeria), A. Fissah (Algiers, Algeria)
| |
EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER
S. Krishnan (Kolkata, India), S. Sharma (Kolkata, India), P. Shahi (Kolkata, India), G. Bhattacharya (Kolkata, India), R. Dhar (Kolkata, India)
| |
Pegfilgrastim drastically lowered risk of febrile neutropenia in Japanese patients with thoracic malignancy receiving chemotherapy - a retrospective single institutional study
T. Iwata (Amagasaki, Japan), A. Yamamoto (Amagasaki, Japan)
| |
Monitoring changes in quality of life in patients with lung cancer under treatment with chemotherapy and co administration of zoledronic acid by using specialized questionnaires
P. Zarogoulidis (Thessaloniki, Greece), T. Tsiouda (ThessalonikiaThessaloniki, Greece), A. Kallinos (AthensThessalonikiaThessaloniki, Greece), A. Rapti (TAthenshessalonikiaThessaloniki, Greece), G. Trakada (Athensssaloniki, Greece), H. Huang (ShanghaiHofTAthenshessalonikiaThessaloniki, China), W. Hohenforst-Schmidt (HofShanghaiHofTAthenshessalonikiaThessaloniki, Germany), I. Tremmas (ThessalonikiHofShanghaiHofTAthenshessalonikiaThessaloniki, Greece), C. Sardeli (ThessalonikiThessalonikiHofShanghaiHofTAthenshessalonikiaThessaloniki, Greece), K. Sapalidis (ThessalonikiThessalonikiThessalonikiHofShanghaiHofTAthenshessalonikiaThessaloniki, Greece)
| |
Music prior to bronchoscopy reduces anxiety in patients with suspected lung cancer
E. Jeppesen (Copenhagen, Denmark), C. Pedersen (Copenhagen, Denmark), K. Larsen (Copenhagen, Denmark), E. Walsted (Copenhagen, Denmark), A. Rehl (Copenhagen, Denmark), J. Ehrenreich (Copenhagen, Denmark), S. Schnoor (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark)
| |
Gender aspects in quality of life of lung cancer patients
M. Koch (Regensburg, Germany), F. Zeman (Regensburg, Germany), H. Jensen (Oslo, Norway), K. Tomaszewski (Krakow, Poland), I. Tomaszewska (Krakow, Poland), K. Hornslien (Oslo, Norway), A. Harle (Poole, United Kingdom), J. Arraras (Pamplona, Spain), O. Morag (Tel Hashomer, Israel), C. Pompili (Leeds, United Kingdom), G. Ioannidis (Nicosia, Cyprus), M. Georgu (Lincoln, United Kingdom), C. Navarra (Rome, Italy), W. Chie (Taipei, Taiwan), C. Johnson (Southampton, United Kingdom), A. Himpel (Heidelberg, Germany), T. Bohrer (Bamberg, Germany), A. Janssens (Edegem, Belgium), D. Kulis (Brussels, Belgium), A. Bottomley (Brussels, Belgium), C. Schulz (Regensburg, Germany), M. Koller (Regensburg, Germany)
| |
Socioeconomic status and lung cancer pathways in southeast London:Friend or Foe?
A. Heitmann (London, United Kingdom), P. Iyer (London, United Kingdom), H. Pandian (London, United Kingdom), G. Hardavella (London, United Kingdom)
| |
Time in lung cancer diagnosis and its prognostic implication
A. Mas Esteve (Lleida, Spain), D. Polanco Alonso (Lleida, Spain), S. Bertran Melines (Lleida, Spain), G. Fierro Barrabés (Lleida, Spain), E. Galera Lozano (Lleida, Spain), A. Seminario Ruíz (Lleida, Spain), G. Suárez Cuartin (Lleida, Spain), S. Gómez Falguera (Lleida, Spain), M. Vilà Justribó (Lleida, Spain), F. Barbé Illa (Lleida, Spain)
| |
Diagnosis, treatment and doctor delays in lung cancer patients who had diagnostic fiberoptic bronchoscopy at Pamukkale University Pulmonary Diseases Clinic
F. Marim (Artvin, Turkey), S. Baser Öncel (Denizli, Turkey), B. Evyapan (Denizli, Turkey), H. Senol (Denizli, Turkey)
| |
The causes of the delay in diagnosis bronchopulmonary cancer
W. Elkhattabi (casablanca, Morocco), l. najah (casablanca, Morocco), H. Jabri (casablanca, Morocco), M. Afif (casablanca, Morocco)
| |
Delays in treatment decisions from lung cancer multi-disciplinary meetings in two centres in North-West, UK.
R. Wang (Preston, United Kingdom), T. Lightburn (Preston, United Kingdom), Y. Lum (Preston, United Kingdom), S. Gudur (Preston, United Kingdom), S. Nicholas (Preston, United Kingdom), S. Mehdi (Preston, United Kingdom)
| |
Quality evaluation of primary care referrals to lung cancer services and their response in South London: Clinical practice in a pragmatic setting.
D. Tsakri (London, United Kingdom), A. Seedat (London, United Kingdom), N. Paizi (London, United Kingdom), R. Turner (London, United Kingdom), G. Hardavella (London, United Kingdom)
| |
Causes of Hospitalization and Mortality in Lung Cancer Patients
C. Gomes Pavão De Matos (Loures, Portugal), V. Sacramento (Loures, Portugal), M. Felizardo (Loures, Portugal), S. Furtado (Loures, Portugal)
| |
Tele-cancer: Reducing time-to-treatment for patients with lung cancer
I. Arosi (Wigan, United Kingdom), K. Heyes (Wigan, United Kingdom), V. Sibanda (Wigan, United Kingdom), R. Sundar (Wigan, United Kingdom)
| |
Quality performance indicators in lung cancer;learning and reflecting on mortality data
G. Hardavella (London, United Kingdom), C. Hobart (London, United Kingdom), R. Turner (London, United Kingdom), G. Warwick (London, United Kingdom), L. Hadley (London, United Kingdom), A. Heitmann (London, United Kingdom), P. Edmonds (London, United Kingdom)
| |
Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
A. Heitmann (London, United Kingdom), H. Pandian (London, United Kingdom), P. Iyer (London, United Kingdom), C. Hobart (London, United Kingdom), G. Hardavella (London, United Kingdom)
| |
When lung cancer was rare: An historical study of prevalence from 1760 .
L. Ollivier (Brest, France), P. Saliou (Brest, France), O. Pradier (Brest, France), G. Quéré (Brest, France), R. Descourt (Brest, France), A. Smolarz (Troyes, France), P. Bore (Brest, France), K. Cherid (Brest, France), A. Blot (Brest, France), G. Le Bihan (Pessac, France), F. Sassier (Brest, France), C. Orione (Brest, France), U. Schick (Brest, France), C. Roge (Morlaix, France)
| |